Moolec Science (NASDAQ:MLEC) Posts Quarterly Earnings Results

Moolec Science (NASDAQ:MLEC) released its earnings results on Thursday. The company reported $47.49 earnings per share (EPS) for the quarter, FiscalAI reports. The firm had revenue of $2.62 million during the quarter.

Moolec Science Trading Up 1.7%

MLEC traded up $0.14 during midday trading on Thursday, hitting $8.48. 13,272 shares of the company were exchanged, compared to its average volume of 205,601. The company’s 50 day simple moving average is $8.44 and its 200 day simple moving average is $7.68. The firm has a market capitalization of $6.19 million, a price-to-earnings ratio of -0.26 and a beta of 0.38. Moolec Science has a 1-year low of $3.08 and a 1-year high of $157.05.

Wall Street Analyst Weigh In

Separately, Wall Street Zen downgraded Moolec Science from a “hold” rating to a “sell” rating in a research report on Sunday, April 26th.

Institutional Investors Weigh In On Moolec Science

An institutional investor recently bought a new position in Moolec Science stock. Citadel Advisors LLC bought a new stake in shares of Moolec Science SA (NASDAQ:MLEC) during the third quarter, according to its most recent 13F filing with the Securities and Exchange Commission. The firm bought 36,218 shares of the company’s stock, valued at approximately $36,000. Citadel Advisors LLC owned 0.90% of Moolec Science as of its most recent SEC filing. Hedge funds and other institutional investors own 0.07% of the company’s stock.

Moolec Science Company Profile

Moolec Science SA, a science-based food ingredient company, focuses on developing real animal proteins in plants using molecular farming. It offers Chymosin SPC, a dairy ingredient; GLA SONOVA, a nutritional oil; POORK+, a plant-based, animal meat free ingredient with porcine proteins in soybeans; and BEEF+, a meat replacement product. It operates in the United States, Europe, and South America. The company was founded in 2020 and is based in Luxembourg.